UHRA-10

has antithrombotic activity; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Kalathottukaren, Manu Thomas: 2 articles (01/2022 - 11/2014)
2.	Kizhakkedathu, Jayachandran N: 2 articles (01/2022 - 11/2014)
3.	Morrissey, James H: 2 articles (01/2022 - 11/2014)
4.	Abbasi, Usama: 1 article (01/2022)
5.	Abbina, Srinivas: 1 article (01/2022)
6.	Gill, Arshdeep: 1 article (01/2022)
7.	Haynes, Charles A: 1 article (01/2022)
8.	La, Chanel C: 1 article (01/2022)
9.	Smith, Stephanie A: 1 article (01/2022)
10.	Vappala, Sreeparna: 1 article (01/2022)

1.	Thrombosis (Thrombus) 11/20/2014 - "Compounds UHRA-9 and UHRA-10 significantly reduced arterial thrombosis in mice. "
2.	Polyps 01/01/2022 - "The polyP inhibitor with mPEG-750 brush layer, mPEG750 UHRA-10, showed superior biocompatibility compared to its mPEG-350 analogs by a number of measured parameters without losing its neutralization activity. "
3.	Hemorrhage 11/20/2014 - "In mouse tail bleeding tests, administration of UHRA-9 or UHRA-10 was associated with significantly less bleeding compared with therapeutically equivalent doses of heparin. "